title: Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population.
abstract: Despite the major role of insulin in regulating apolipoprotein C-III (apo C-III) production, little is known about the relationship between apo C-III and insulin resistance. We examined this relationship, and the association of apo C-III with dyslipidemia, in a triethnic sample of 168 subjects with normoglycemia or type 2 diabetes. African-Americans had lower triglycerides (1.21 +/- 0.11 mmol/l) compared with Hispanics (2.01 +/- 0.14 mmol/l) and white non-Hispanics (1.83 +/- 0.15 mmol/l), regardless of gender and type 2 diabetes status (P < 0.01), but this difference was partially accounted for by ethnic difference in apo C-III levels. Metabolic syndrome was associated with high apo C-III (> 14 mg/dl) in Hispanics (OR = 5.6; 95%CI: 1.3-23.4) and white non-Hispanics (OR = 6.9; 95%CI: 1.3-36.4), but not in African-Americans. Apo C-III was the best predictor of triglycerides (R2 = 0.54, P < 0.001), after accounting for demographic and clinical variables. We found an inverse relationship between apo C-III levels and low-density lipoprotein (LDL) particle size in the type 2 diabetes subjects with (r = -0.36, P = 0.02) and without (r = -0.47, P = 0.02) the metabolic syndrome, but in normoglycemic subjects an inverse relationship was evident only in metabolic syndrome subjects (r = -0.52, P < 0.01). These results suggest that higher apo C-III may contribute to the increased cardiovascular risk in subjects with insulin resistance and type 2 diabetes through its effects on triglycerides and LDL particle size.
authors.affiliation: University of Miami Miller School of Medicine, Miami, FL, USA. hflorez@med.miami.edu
authors.forename: Hermes
authors.initials: H
authors.lastname: Florez
authors.forename: Armando
authors.initials: A
authors.lastname: Mendez
authors.forename: Paul
authors.initials: P
authors.lastname: Casanova-Romero
authors.forename: Carmen
authors.initials: C
authors.lastname: Larreal-Urdaneta
authors.forename: Sumaya
authors.initials: S
authors.lastname: Castillo-Florez
authors.forename: David
authors.initials: D
authors.lastname: Lee
authors.forename: Ronald
authors.initials: R
authors.lastname: Goldberg
mesh_terms: D000328:Adult; D000368:Aged; D053305:Apolipoprotein C-III / Q000097:blood*; D002318:Cardiovascular Diseases / Q000209:etiology; D003924:Diabetes Mellitus, Type 2 / Q000208:ethnology / Q000378:metabolism*; D050171:Dyslipidemias / Q000208:ethnology / Q000378:metabolism; D005006:Ethnicity; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000208:ethnology / Q000378:metabolism*; D007333:Insulin Resistance; D008077:Lipoproteins, LDL / Q000097:blood*; D008297:Male; D024821:Metabolic Syndrome / Q000208:ethnology / Q000378:metabolism*; D008875:Middle Aged; D010316:Particle Size; D012307:Risk Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D053305:Apolipoprotein C-III; D008077:Lipoproteins, LDL; D014280:Triglycerides